Pharmaesthetics is a company that considers quality to be one of its main pillars. Good regulatory compliance with all its processes and systems has resulted in two important milestones in 2025. In an inspection in February this year, the company was certified in Good Manufacturing Practices (GMP) by ANVISA. More recently, in September, it was awarded NBR ISO 13.485 certification, an internationally recognized standard that attests to the quality system of medical device manufacturers.
A ISO stands for International Organization for Standardization, an international initiative focused on establishing quality standards that are recognizable throughout the world. To receive an ISO certificate, a company needs to meet numerous requirements regarding the quality of its manufacturing and management processes, It's also important to take care of your production environment, your work team and, of course, your final product.
See this photo on Instagram
NBR ISO 13.485, on the other hand, is related to the quality management of medical devices and materials and in order to obtain it, the company must prove that it complies with the high standards of international harmonization. Everything is assessed, from design to production, technical and biological surveillance, good customer service and the entire product cycle on the market. To have received this certificate and, what's more, to have earned it without any non-compliance, is a source of great pride for the Pharmaesthetics Group and reaffirms its commitment to the highest standards of quality, safety and regulatory compliance demanded by the global market.
Founded seven years ago and fully active in the market for four, Since its inception, the company has been operating in accordance with quality precepts, transforming these precepts into culture. Having quality as part of the company's culture is a demonstration of respect for our suppliers, our employees, the regulatory bodies of the markets in which we operate and, above all, respect for our end customers.
Receiving two highly relevant certifications in good manufacturing practices, by ANVISA and the ISO13.485 standard, would already be major achievements in itself, but they also had a high point in their histories: both certifications took place without any non-compliance.
“These certifications and approvals reinforce our purpose of offering effective, safe and technologically advanced products, respecting the individuality of each patient and contributing to the self-esteem and health of thousands of people,” he says. Claudio Cabral, Industrial Director at Pharmaesthetics.
